Cargando…

Single-institution analysis of the prevalence, indications and outcomes of end-of-life radiotherapy

BACKGROUND: Radiotherapy plays an important role for symptom control in advanced stage cancer patients. Yet patients need to be carefully selected, and its use and benefits must be weighed against time spent under treatment and patient priorities in the last phase of life. In this study, we assess p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Christ, Sebastian M., Schettle, Markus, Seiler, Annina, Guckenberger, Matthias, Blum, David, Andratschke, Nicolaus, Hertler, Caroline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273096/ https://www.ncbi.nlm.nih.gov/pubmed/34286114 http://dx.doi.org/10.1016/j.ctro.2021.06.010

Ejemplares similares

Validation and extension of the METSSS score in a metastatic cancer patient cohort after palliative radiotherapy within the last phase of life
por: Christ, Sebastian M., et al.
Publicado: (2022)

Prevalence and predictors for 72-h mortality after transfer to acute palliative care unit
por: Christ, Sebastian M., et al.
Publicado: (2022)

Sex-specific and gender-specific aspects in patient-reported outcomes
por: Hertler, Caroline, et al.
Publicado: (2020)

Socio-economic determinants for the place of last care: results from the acute palliative care unit of a large comprehensive cancer center in a high-income country in Europe
por: Christ, Sebastian M., et al.
Publicado: (2023)

Quality-of-life and toxicity in cancer patients treated with multiple courses of radiation therapy
por: Ahmadsei, Maiwand, et al.
Publicado: (2022)

Radiotherapy for glioblastoma patients with poor performance status
por: Schröder, Christina, et al.
Publicado: (2021)

Continuity and coordination of care in highly selected chronic cancer patients treated with multiple repeat radiation therapy
por: Christ, Sebastian M., et al.
Publicado: (2021)

Mortality during or shortly after curative-intent radio-(chemo-) therapy over the last decade at a large comprehensive cancer center
por: Christ, Sebastian M., et al.
Publicado: (2023)

Subcutaneous Levetiracetam Application Sustains Therapeutic Drug Levels
por: Westphal, Sophia, et al.
Publicado: (2021)

Stereotactic body radiotherapy to defer systemic therapy in patients with oligorecurrent disease
por: Willmann, Jonas, et al.
Publicado: (2022)

Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma?
por: Rühle, Alexander, et al.
Publicado: (2019)

Prospective assessment of stress and health concerns of radiation oncology staff during the COVID-19 pandemic
por: Christ, Sebastian M., et al.
Publicado: (2022)

Efficacy and safety analysis in metastatic cancer patients treated with multiple courses of repeat radiation therapy
por: Ahmadsei, Maiwand, et al.
Publicado: (2023)

Repeated Courses of Radiosurgery for New Brain Metastases to Defer Whole Brain Radiotherapy: Feasibility and Outcome With Validation of the New Prognostic Metric Brain Metastasis Velocity
por: Fritz, Corinna, et al.
Publicado: (2018)

Re-irradiation of recurrent IDH-wildtype glioblastoma in the bevacizumab and immunotherapy era: Target delineation, outcomes and patterns of recurrence
por: Christ, Sebastian M., et al.
Publicado: (2023)

Intra- and inter-fraction breath-hold variations and margins for radiotherapy of abdominal targets
por: Ehrbar, Stefanie, et al.
Publicado: (2023)

Synthetic computed tomography for low-field magnetic resonance-guided radiotherapy in the abdomen
por: Lapaeva, Mariia, et al.
Publicado: (2022)

Head and neck radiotherapy on the MR linac: a multicenter planning challenge amongst MRIdian platform users
por: Chamberlain, Madalyne, et al.
Publicado: (2021)

Patient-specific quality assurance strategies for synthetic computed tomography in magnetic resonance-only radiotherapy of the abdomen
por: Dal Bello, Riccardo, et al.
Publicado: (2023)

In-field stereotactic body radiotherapy (SBRT) reirradiation for pulmonary malignancies as a multicentre analysis of the German Society of Radiation Oncology (DEGRO)
por: John, Caroline, et al.
Publicado: (2021)

Radiation myelitis after hypofractionated radiotherapy with concomitant gefitinib
por: Lewitzki, Victor, et al.
Publicado: (2015)

Synthetic computed tomography for low-field magnetic resonance-only radiotherapy in head-and-neck cancer using residual vision transformers
por: La Greca Saint-Esteven, Agustina, et al.
Publicado: (2023)

Improved plan quality with automated radiotherapy planning for whole brain with hippocampus sparing: a comparison to the RTOG 0933 trial
por: Krayenbuehl, J., et al.
Publicado: (2017)

Correction to: Improved plan quality with automated radiotherapy planning for whole brain with hippocampus sparing: a comparison to the RTOG 0933 trial
por: Krayenbuehl, J., et al.
Publicado: (2017)

Dosimetric and geometric end-to-end accuracy of a magnetic resonance guided linear accelerator
por: Stark, Luisa S., et al.
Publicado: (2020)

Stereotactic Body Radiation Therapy (SBRT) as Salvage Therapy for Oligorecurrent Pleural Mesothelioma After Multi-Modality Therapy
por: Schröder, Christina, et al.
Publicado: (2019)

A review of clinical trials of cetuximab combined with radiotherapy for non-small cell lung cancer
por: Nieder, Carsten, et al.
Publicado: (2012)

Personalized radiotherapy of brain metastases: survival prediction by means of dichotomized or differentiated blood test results?
por: Nieder, Carsten, et al.
Publicado: (2023)

MR-Guided Adaptive Radiotherapy for Head and Neck Cancer: Prospective Evaluation of Migration and Anatomical Changes of the Major Salivary Glands
por: van Timmeren, Janita E., et al.
Publicado: (2021)

Benefit of replanning in MR-guided online adaptive radiation therapy in the treatment of liver metastasis
por: Mayinger, Michael, et al.
Publicado: (2021)

Management of multiple brain metastases: a patterns of care survey within the German Society for Radiation Oncology
por: Kraft, Johannes, et al.
Publicado: (2021)

Recognition of and treatment recommendations for oligometastatic disease in multidisciplinary tumor boards
por: Christ, Sebastian M., et al.
Publicado: (2022)

Dosimetric analysis of 17 cardiac Sub-structures, Toxicity, and survival in ultra central lung tumor patients treated with SBRT
por: Ahmadsei, Maiwand, et al.
Publicado: (2023)

Definition of stereotactic body radiotherapy: Principles and practice for the treatment of stage I non-small cell lung cancer
por: Guckenberger, M., et al.
Publicado: (2013)

Comparison of beam segment versus full plan re-optimization in daily magnetic resonance imaging-guided online-adaptive radiotherapy
por: van Timmeren, Janita E., et al.
Publicado: (2021)

Operating procedures, risk management and challenges during implementation of adaptive and non-adaptive MR-guided radiotherapy: 1-year single-center experience
por: Garcia Schüler, Helena Isabel, et al.
Publicado: (2021)

Robustness of radiomic features in magnetic resonance imaging for patients with glioblastoma: Multi-center study
por: Saltybaeva, Natalia, et al.
Publicado: (2022)

Corrigendum to “Robustness of radiomic features in magnetic resonance imaging for patients with glioblastoma: Multi-center study” [Phys. Imaging Radiat. Oncol. 22 (2022) 131–136]
por: Saltybaeva, Natalia, et al.
Publicado: (2022)

Palliative radiotherapy near the end of life
por: Wu, Susan Y., et al.
Publicado: (2019)

MLTI-09. UNDERWEIGHT AND WEIGHT LOSS ARE PREDICTORS OF POOR OUTCOME IN PATIENTS WITH BRAIN METASTASIS
por: Weller, Michael, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sehrephbq6o9rh5s28v2f3mm26